Richard D. Truesdell, Jr.
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/14523_rtrue_0.jpg?itok=mUnbqwyG)
Filters
Davis Polk Advises Fogo de Chão, Inc. on Its Follow-on Offering
Davis Polk advised Fogo de Chão, Inc. in connection with an SEC-registered secondary offering of 4,500,000 common shares by certain selling stockholders, for an aggregate price to the…
Kinsale Capital Group, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $150.4 million follow-on offering of 4,557,774 shares of common stock of…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible…
Davis Polk Advises Tyson Foods on Its Acquisition of AdvancePierre Foods
Davis Polk is advising Tyson Foods, Inc. on its approximately $4.2 billion acquisition of AdvancePierre Foods Holdings, Inc. The transaction, which is expected to close in the third quarter…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 5,050,505 shares of common stock of…
Galapagos NV €363.9 Million Follow-On Offering of American Depositary Shares
Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in the form of American depositary shares, which includes the full…
Hostess Common Stock Secondary Offering
Davis Polk advised the underwriters in connection with the $352.5 million SEC-registered secondary offering of 23,116,416 shares of Class A common stock of Hostess Brands, Inc. by…
Evolent Health Common Stock Secondary Offering
Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…
Davis Polk Advises Heineken N.V. on Its $1.75 Billion Global Senior Notes Offering
Davis Polk advised Heineken N.V. on its offering of $1.1 billion aggregate principal amount of its 3.50% senior notes due 2028 and $650 million aggregate principal amount of its 4.35%…
REGENXBIO Follow-On Common Stock Offering
Davis Polk advised the representatives of the underwriters in connection with the $75.9 million offering of 3,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…